145 related articles for article (PubMed ID: 24218253)
1. Quantification of complement C5b-9 binding to cells by flow cytometry.
Moskovich O; Fishelson Z
Methods Mol Biol; 2014; 1100():103-8. PubMed ID: 24218253
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
3. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
Rollins SA; Sims PJ
J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
[TBL] [Abstract][Full Text] [Related]
4. Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice.
Fu X; Ju J; Lin Z; Xiao W; Li X; Zhuang B; Zhang T; Ma X; Li X; Ma C; Su W; Wang Y; Qin X; Liang S
Sci Rep; 2016 Jul; 6():30239. PubMed ID: 27444648
[TBL] [Abstract][Full Text] [Related]
5. Mortalin/GRP75 binds to complement C9 and plays a role in resistance to complement-dependent cytotoxicity.
Saar Ray M; Moskovich O; Iosefson O; Fishelson Z
J Biol Chem; 2014 May; 289(21):15014-22. PubMed ID: 24719326
[TBL] [Abstract][Full Text] [Related]
6. The deposition of C5b-9 complexes and its precursors on E. coli J5 during complement activation enhances uptake and toxicities of gentamicin.
Bloch EF; Morrison K; McDonald-Pinkett S; Baskin S; Campbell S; Peters S; Dillahunt S; Evans D; Lucas S; Macatangay A; Kanaan Y
Immunol Invest; 2008; 37(3):245-61. PubMed ID: 18389443
[TBL] [Abstract][Full Text] [Related]
7. Several epitopes on native human complement C9 are involved in interaction with the C5b-8 complex and other C9 molecules.
Kontermann R; Deppisch R; Rauterberg EW
Eur J Immunol; 1990 Mar; 20(3):623-8. PubMed ID: 1690659
[TBL] [Abstract][Full Text] [Related]
8. Exposure to the complement C5b-9 complex sensitizes 661W photoreceptor cells to both apoptosis and necroptosis.
Shi H; Williams JA; Guo L; Stampoulis D; Francesca Cordeiro M; Moss SE
Apoptosis; 2015 Apr; 20(4):433-43. PubMed ID: 25735751
[TBL] [Abstract][Full Text] [Related]
9. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.
Joiner KA; Tartanian AB; Hammer CH; Schweinle JE
J Immunol; 1989 Jun; 142(12):4450-7. PubMed ID: 2656866
[TBL] [Abstract][Full Text] [Related]
10. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore.
Bhakdi S; Tranum-Jensen J
J Immunol; 1986 Apr; 136(8):2999-3005. PubMed ID: 3958488
[TBL] [Abstract][Full Text] [Related]
11. Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9.
Puentes SM; Da Silva RP; Sacks DL; Hammer CH; Joiner KA
J Immunol; 1990 Dec; 145(12):4311-6. PubMed ID: 2147941
[TBL] [Abstract][Full Text] [Related]
12. Activation of human complement by IgG antisperm antibody and the demonstration of C3 and C5b-9-mediated immune injury to human sperm.
D'Cruz OJ; Haas GG; Wang BL; DeBault LE
J Immunol; 1991 Jan; 146(2):611-20. PubMed ID: 1987279
[TBL] [Abstract][Full Text] [Related]
13. Complement C5b-9 and Cancer: Mechanisms of Cell Damage, Cancer Counteractions, and Approaches for Intervention.
Fishelson Z; Kirschfink M
Front Immunol; 2019; 10():752. PubMed ID: 31024572
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical determination of complement activation in joint tissues of patients with rheumatoid arthritis and osteoarthritis using neoantigen-specific monoclonal antibodies.
Kemp PA; Spragg JH; Brown JC; Morgan BP; Gunn CA; Taylor PW
J Clin Lab Immunol; 1992; 37(4):147-62. PubMed ID: 1285067
[TBL] [Abstract][Full Text] [Related]
15. Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing.
Bloch EF; Schmetz MA; Foulds J; Hammer CH; Frank MM; Joiner KA
J Immunol; 1987 Feb; 138(3):842-8. PubMed ID: 3100618
[TBL] [Abstract][Full Text] [Related]
16. Comparison of channels formed by poly C9, C5b-8 and the membrane attack complex of complement.
Zalman LS; Müller-Eberhard HJ
Mol Immunol; 1990 Jun; 27(6):533-7. PubMed ID: 1696352
[TBL] [Abstract][Full Text] [Related]
17. CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9.
Farkas I; Baranyi L; Ishikawa Y; Okada N; Bohata C; Budai D; Fukuda A; Imai M; Okada H
J Physiol; 2002 Mar; 539(Pt 2):537-45. PubMed ID: 11882685
[TBL] [Abstract][Full Text] [Related]
18. Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement.
Stewart JL; Kolb WP; Sodetz JM
J Immunol; 1987 Sep; 139(6):1960-4. PubMed ID: 3624872
[TBL] [Abstract][Full Text] [Related]
19. Killing of gram-negative bacteria by complement. Fractionation of cell membranes after complement C5b-9 deposition on to the surface of Salmonella minnesota Re595.
Tomlinson S; Taylor PW; Morgan BP; Luzio JP
Biochem J; 1989 Oct; 263(2):505-11. PubMed ID: 2597121
[TBL] [Abstract][Full Text] [Related]
20. Mortalin/GRP75 promotes release of membrane vesicles from immune attacked cells and protection from complement-mediated lysis.
Pilzer D; Fishelson Z
Int Immunol; 2005 Sep; 17(9):1239-48. PubMed ID: 16091382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
